Table 1 Baseline characteristics of the study cohort (N = 145).

From: Pulmonary recovery from COVID-19 in patients with metabolic diseases: a longitudinal prospective cohort study

Patient characteristics

 

Mean age (years (SD))

57.3 (14.3)

Gender (N female (%))

63 (43.4)

BMI and obesity grading

 Mean BMI (kg/m2 (SD))

26.4 (4.7)

 BMI < 25 kg/m2 (N (%))

57 (39.3)

 BMI 25–30 kg/m2 (N (%))

59 (40.7)

 BMI 30–35 kg/m2 (N (%))

21 (14.5)

 BMI 35–40 kg/m2 (N (%))

6 (4.1)

 BMI ≥ 40 kg/m2 (N (%))

2 (1.4)

Comorbidities

N (%)

 No comorbidities

33 (22.8)

 ≥ 3 comorbidities

74 (51.0)

 Metabolic diseases

63 (43.4)

  Diabetes mellitus type 1

0 (0.0)

  Diabetes mellitus type 2

24 (16.6)

  Hypercholesterolemia

27 (18.6)

  Hypertriglyceridemia

2 (1.4)

 Cardiovascular disease

58 (40.0)

 Arterial hypertension

44 (30.3)

 Pulmonary disease

27 (18.6)

 Chronic kidney disease

10 (6.9)

 Chronic liver disease

8 (5.5)

 Gastrointestinal disease

20 (13.8)

 Malignancy

17 (11.7)

 Immune suppression

9 (6.2)